Postoperative Pancreatic Fistula in Patients Undergoing Pancreaticoduodenectomy
popf
2 other identifiers
expanded_access
N/A
1 country
2
Brief Summary
Pancreaticoduodenectomy (PD) is a complex procedure performed in patients with malignant or benign tumors of the pancreatic head and periampullary region, associated with high morbidity and mortality. Postoperative pancreatic fistula (POPF) is the most common and clinically significant complication following PD. In this study, the investigators aim to predict pancreatic fistula using the C-reactive protein-albumin ratio (CAR). The total number of participants expected to be included in this research comprises patients who underwent PD between 2017 and 2023 and developed pancreatic fistula. The participants invitation is based on the detection of a pancreatic fistula. This study is conducted for research purposes and participation is voluntary. No interventions will be performed on the participants as part of this study; however, we have prepared this form to obtain participant permission to gather certain information. If the participants consent to the use of information for scientific purposes with the guarantee of confidentiality, they will be asked to sign a consent form.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2024
CompletedFirst Posted
Study publicly available on registry
March 8, 2024
CompletedMarch 8, 2024
February 1, 2024
February 16, 2024
March 7, 2024
Conditions
Keywords
Interventions
In this study, predicting pancreatic fistula before surgery will reduce postoperative complications and mortality.
Eligibility Criteria
You may qualify if:
- Patients aged between 18 and 80 years
- Diagnosed with pancreatic cancer
- Patients without recurrence
You may not qualify if:
- Patients who underwent total pancreatectomy
- Data were not available
- Patients outside the specified age range
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hitit University Erol olçok Traning and research Hospital
Çorum, Merkez, 19000, Turkey (Türkiye)
Hitit University Erol olçok Traning and resourge Hospital
Çorum, Merkez, 19000, Turkey (Türkiye)
Related Publications (1)
Sakamoto T, Yagyu Y, Uchinaka EI, Morimoto M, Hanaki T, Tokuyasu N, Honjo S, Fujiwara Y. Predictive Significance of C-reactive Protein-to-albumin Ratio for Postoperative Pancreatic Fistula After Pancreaticoduodenectomy. Anticancer Res. 2019 Nov;39(11):6283-6290. doi: 10.21873/anticanres.13838.
PMID: 31704858BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- expanded access
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 16, 2024
First Posted
March 8, 2024
Last Updated
March 8, 2024
Record last verified: 2024-02